Spotlight Therapeutics
Patents held now
No granted US patent is recorded under this name. The published applications below are what the record holds.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 4 abandoned
Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.
| Application | Title | Filed | Status |
|---|---|---|---|
| 18/640,660 | Guide RNAs and Uses Thereof | Apr 19, 2024 | Pending |
| 18/481,874 | Adar Specific Guide RNAs and Uses Thereof | Oct 5, 2023 | Pending |
| 18/339,859 | Nucleic Acid Binding Protein Formulations and Uses Thereof | Jun 22, 2023 | Abandoned |
| 17/507,324 | Methods and Compositions for Nucleic Acid-Guided Nuclease Cell Targeting Screen | Oct 21, 2021 | Abandoned |
| 17/481,056 | Targeted Active Gene Editing Agent and Methods of Use | Sep 21, 2021 | Abandoned |
| 17/480,913 | Targeted Active Gene Editing Agent and Methods of Use | Sep 21, 2021 | Abandoned |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built